Caribou Biosciences Secures $30,000,000 Series B Funding Round

  • Feed Type
  • Date
    5/16/2016
  • Company Name
    Caribou Biosciences
  • Mailing Address
    2929 7th Street Berkeley, CA 94710 USA
  • Company Description
    Caribou is a developer of cellular engineering and analysis solutions based on CRISPR technologies. Caribou’s tools and technologies provide transformative capabilities to therapeutic development, agricultural biotechnology, industrial biotechnology, and basic and applied biological research.
  • Website
    http://www.cariboubio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The proceeds from this financing will enable us to continue to expand our industry-leading CRISPR gene editing technology platform and accelerate our efforts in highly promising application areas in agriculture, therapeutics, biological research, and industrial biotechnology.
  • M&A Terms
  • Venture Investor
    Anterra Capital
  • Venture Investor
    Heritage Group
  • Venture Investor
    Maverick Capital
  • Venture Investor
    Pontifax Fund
  • Venture Investor
    Novartis Venture Fund
  • Venture Investor
    F-Prime Capital
  • Venture Investor
    Mission Bay Capital

Trending on Xconomy